Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Human normal immunoglobulin for preventing primary infection in chronic lymphocytic leukaemia	Human Immunoglobulin (TAK-771)	Chronic lymphocytic leukaemia (CLL)	Haematological Cancer and Lymphomas	2024	View \| Download
Human immunoglobulin with recombinant human hyaluronidase maintenance therapy for treating multifocal motor neuropathy	Human Immunoglobulin (TAK-771)	Multifocal motor neuropathy	Neurology	2024	View \| Download
Human C1-esterase inhibitor (subcutaneous injection) for preventing hereditary angioedema	Human C1 esterase inhibitor (Berinert)	Hereditary angioedema (HAE)	Genetic Disorders , Immunology	2023	View \| Download
Human acellular vessel for vascular access for haemodialysis in end-stage renal disease	Human Acellular Vessel (HumaGraft; Humacyl)	Arterial venous access	Cardiovascular System	2019	View \| Download
Histamine dihydrochloride (Ceplene) in combination with low dose interleukin-2 as maintenance treatment for acute myeloid leukaemia	Histamine dihydrochloride (Ceplene) , Low-dose aldesluekin	Acute myeloid leukaemia (AML)	Haematological Cancer and Lymphomas	2019	View \| Download
High-dose aflibercept for diabetic macular oedema	Aflibercept	Diabetic macular oedema	Endocrine Nutritional and Metabolic Disorders , Ophthalmology	2022	View \| Download
High dose aflibercept for treating neovascular age-related macular degeneration (nAMD)	Aflibercept	Age-related macular degeneration (AMD)	Ophthalmology	2022	View \| Download
Guselkumab for treating ulcerative colitis	Guselkumab (Tremfya; CNTO-1959)	Ulcerative colitis	Gastroenterology	2022	View \| Download
Guselkumab for treating moderately to severely active Crohn’s disease	Guselkumab (Tremfya; CNTO-1959)	Crohn's disease	Gastroenterology , Immunology	2022	View \| Download
Guselkumab for treating chronic plaque psoriasis in children aged 6 to 17 years	Guselkumab (Tremfya; CNTO-1959)	Plaque psoriasis	Dermatology	2024	View \| Download